Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
Go back to Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 4.18 +0.02 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.16 | 52 Week High | $ | |||
| Open | $4.20 | 52 Week Low | $ | |||
| Day High | $4.21 | P/E | N/A | |||
| Day Low | $4.09 | EPS | $ | |||
| Volume | 699,419 | |||||

